Monitoring fetal immune development in human pregnancies: current concepts and future goals

Standard

Monitoring fetal immune development in human pregnancies: current concepts and future goals. / Pagenkemper, Mirja; Diemert, Anke.

in: J REPROD IMMUNOL, Jahrgang 104, 01.10.2014, S. 49-53.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{d96e359b3fdf485aa1f30162135c00b6,
title = "Monitoring fetal immune development in human pregnancies: current concepts and future goals",
abstract = "The vast majority of the current knowledge on immune development in the fetal period has been gained from animal studies, particularly from mouse models. This has led to a great improvement in our current understanding of immune ontogeny. However, it has also become clear that in many ways the mouse model of pregnancy differs from the situation in human pregnancy, such as the degree and importance of trophoblast invasion, the kind of MHC class repertoire of the extravillous trophoblast cells, and differences concerning the development and regulation of T-cells. It will be of paramount importance to develop non-invasive screening methods to assess fetal immune development in humans. The focus of this mini-review is to discuss how prenatal ultrasound evaluation can be used as a tool to monitor fetal immune development in human pregnancies. To identify the fetuses at risk of immune disorders could be the first step to developing prevention strategies in the future.",
author = "Mirja Pagenkemper and Anke Diemert",
note = "Copyright {\textcopyright} 2014 Elsevier Ireland Ltd. All rights reserved.",
year = "2014",
month = oct,
day = "1",
doi = "10.1016/j.jri.2014.06.001",
language = "English",
volume = "104",
pages = "49--53",
journal = "J REPROD IMMUNOL",
issn = "0165-0378",
publisher = "Elsevier Ireland Ltd",

}

RIS

TY - JOUR

T1 - Monitoring fetal immune development in human pregnancies: current concepts and future goals

AU - Pagenkemper, Mirja

AU - Diemert, Anke

N1 - Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

PY - 2014/10/1

Y1 - 2014/10/1

N2 - The vast majority of the current knowledge on immune development in the fetal period has been gained from animal studies, particularly from mouse models. This has led to a great improvement in our current understanding of immune ontogeny. However, it has also become clear that in many ways the mouse model of pregnancy differs from the situation in human pregnancy, such as the degree and importance of trophoblast invasion, the kind of MHC class repertoire of the extravillous trophoblast cells, and differences concerning the development and regulation of T-cells. It will be of paramount importance to develop non-invasive screening methods to assess fetal immune development in humans. The focus of this mini-review is to discuss how prenatal ultrasound evaluation can be used as a tool to monitor fetal immune development in human pregnancies. To identify the fetuses at risk of immune disorders could be the first step to developing prevention strategies in the future.

AB - The vast majority of the current knowledge on immune development in the fetal period has been gained from animal studies, particularly from mouse models. This has led to a great improvement in our current understanding of immune ontogeny. However, it has also become clear that in many ways the mouse model of pregnancy differs from the situation in human pregnancy, such as the degree and importance of trophoblast invasion, the kind of MHC class repertoire of the extravillous trophoblast cells, and differences concerning the development and regulation of T-cells. It will be of paramount importance to develop non-invasive screening methods to assess fetal immune development in humans. The focus of this mini-review is to discuss how prenatal ultrasound evaluation can be used as a tool to monitor fetal immune development in human pregnancies. To identify the fetuses at risk of immune disorders could be the first step to developing prevention strategies in the future.

U2 - 10.1016/j.jri.2014.06.001

DO - 10.1016/j.jri.2014.06.001

M3 - SCORING: Journal article

C2 - 25124491

VL - 104

SP - 49

EP - 53

JO - J REPROD IMMUNOL

JF - J REPROD IMMUNOL

SN - 0165-0378

ER -